02. Multitarget therapy with a corticosteroid, cyclosporine and mycophenolate mofetil for idiopathic membranous nephropathy: a prospective randomized controlled trial.
03. The significance of anti-PLA2R in diabetic kidney disease: Truly a false positive?
04. Membranous nephropathy treatment standard.
05. Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy.
06. Obinutuzumab in Refractory Phospholipase A2 receptor-Associated Membranous Nephropathy With Severe CKD.
07. Obinutuzumab as Initial or Second-line Therapy in Patients with Primary Membranous Nephropathy.
08. NELL-1–associated membranous nephropathy linked to skin fairness cream use: insights from an Indian case series- ;